BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20420661)

  • 21. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
    Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
    Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.
    Park JM; Kim MJ; Noh JY; Yun TG; Kang MJ; Lee SG; Yoo BC; Pyun JC
    J Am Soc Mass Spectrom; 2020 Apr; 31(4):917-926. PubMed ID: 32154716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
    Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
    Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
    Cazares LH; Diaz JI; Drake RR; Semmes OJ
    Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
    Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
    Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Zhu XD; Su F; Liang ZG; Li L; Qu S; Liang X; Wang Q; Liang SX; Chen L
    Int J Clin Oncol; 2014 Aug; 19(4):579-85. PubMed ID: 24072388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
    Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
    Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of the short-term efficacy of thymectomy for myasthenia gravis with serum protein profiles.
    Wu GY; Pang JZ; Cheng C; Lu JJ; Ma J; Gu Y; Zhong FT; Luo HH
    Chin Med J (Engl); 2009 Jul; 122(14):1625-30. PubMed ID: 19719962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry].
    Ziganshin RKh; Alekseev DG; Arapidi GP; Ivanov VT; Moshkovskiĭ SA; Govorun VM
    Biomed Khim; 2008; 54(4):408-19. PubMed ID: 18988457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.